136 related articles for article (PubMed ID: 12394834)
1. Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates.
Xu H; Tadaki DK; Elster EA; Burkly LC; Berning JD; Cruzata F; Kampen RL; Montgomery SP; Patterson NB; Harlan DM; Kirk AD
Transplantation; 2002 Oct; 74(7):940-3. PubMed ID: 12394834
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
3. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
Xu H; Elster EA; Blair PJ; Burkly LC; Tadaki DK; Harlan DM; Kirk AD
Am J Transplant; 2003 Nov; 3(11):1350-4. PubMed ID: 14525594
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody.
Pierson RN; Chang AC; Blum MG; Blair KS; Scott MA; Atkinson JB; Collins BJ; Zhang JP; Thomas DW; Burkly LC; Miller GG
Transplantation; 1999 Dec; 68(11):1800-5. PubMed ID: 10609959
[TBL] [Abstract][Full Text] [Related]
6. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
Kirk AD; Burkly LC; Batty DS; Baumgartner RE; Berning JD; Buchanan K; Fechner JH; Germond RL; Kampen RL; Patterson NB; Swanson SJ; Tadaki DK; TenHoor CN; White L; Knechtle SJ; Harlan DM
Nat Med; 1999 Jun; 5(6):686-93. PubMed ID: 10371508
[TBL] [Abstract][Full Text] [Related]
7. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
8. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
9. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
[TBL] [Abstract][Full Text] [Related]
11. Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti-CD154-Treated Monkeys.
Zhang T; Azimzadeh AM; Sun W; O'Neill NA; Sievert E; Bergbower E; Braileanu G; Burdorf L; Cheng X; Monahan T; Dahi S; Harris DG; Rybak E; Welty E; Kronfli A; Avon C; Pierson RN
Transplantation; 2018 Mar; 102(3):e90-e100. PubMed ID: 29319621
[TBL] [Abstract][Full Text] [Related]
12. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD40 ligand antibody permits regeneration through peripheral nerve allografts in a nonhuman primate model.
Brenner MJ; Jensen JN; Lowe JB; Myckatyn TM; Fox IK; Hunter DA; Mohanakumar T; Mackinnon SE
Plast Reconstr Surg; 2004 Dec; 114(7):1802-14; discussion 1815-7. PubMed ID: 15577351
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
[TBL] [Abstract][Full Text] [Related]
15. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
16. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
Xu H; Elster E; Batty D; Berning J; Burkly L; Kampen R; Swanson S; Tadaki D; Harlan D; Kirk A
Transplant Proc; 2001; 33(1-2):223-4. PubMed ID: 11266788
[No Abstract] [Full Text] [Related]
17. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.
Kawai T; Sogawa H; Boskovic S; Abrahamian G; Smith RN; Wee SL; Andrews D; Nadazdin O; Koyama I; Sykes M; Winn HJ; Colvin RB; Sachs DH; Cosimi AB
Am J Transplant; 2004 Sep; 4(9):1391-8. PubMed ID: 15307826
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
[TBL] [Abstract][Full Text] [Related]
20. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
